CLINICAL_TRIALS
withdrawal
· 2017-02-02
Clinical Trial Update: Clonidine for Sleep Disturbances in Children With Autism Spectrum Disorder [Phase 2]
Summary
A Phase 2 clinical trial evaluating clonidine for sleep disturbances in children with autism spectrum disorder has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ohio State University | Conditions: Autism Spectrum Disorder | Phase 2 | Status: WITHDRAWN